- Home
- STC vs HCM Comparison
STC vs HCM Comparison
Compare STC & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STC | HCM |
|---|---|---|
| Founded | 1893 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | STC | HCM |
|---|---|---|
| Price | $65.81 | $16.04 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 2 | 1 |
| Target Price | ★ $81.50 | $13.75 |
| AVG Volume (30 Days) | ★ 254.8K | 59.0K |
| Earning Date | 02-04-2026 | 08-07-2025 |
| Dividend Yield | ★ 3.18% | N/A |
| EPS Growth | ★ 69.60 | N/A |
| EPS | ★ 3.60 | 0.53 |
| Revenue | ★ $2,796,513,000.00 | $602,197,000.00 |
| Revenue This Year | $17.75 | N/A |
| Revenue Next Year | $13.92 | $15.54 |
| P/E Ratio | $18.35 | ★ $5.89 |
| Revenue Growth | ★ 16.09 | N/A |
| 52 Week Low | $56.39 | $11.51 |
| 52 Week High | $78.61 | $19.50 |
Technical Indicators
Market Signals| Indicator | STC | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 34.36 | 75.72 |
| Support Level | $65.09 | $14.63 |
| Resistance Level | $69.01 | $15.00 |
| Average True Range (ATR) | 2.00 | 0.42 |
| MACD | -0.38 | 0.26 |
| Stochastic Oscillator | 18.99 | 90.63 |
Price Performance
Historical ComparisonAbout STC Stewart Information Services Corporation
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.